OGN Latest Headlines

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (SRPT) and Organon (OGN)

at www.tipranks.com (Wed, 21-Jan 4:10 AM)

FDA Extends NEXPLANON Implant Duration to 5 Years: OGN Advances Women’s Health With Broader Patient Inclusion

Market Chameleon (Tue, 20-Jan 11:45 AM)

Organon gains on report of Sun Pharmaceutical interest

at seekingalpha.com (Tue, 20-Jan 9:38 AM)

M&A News: India’s Sun Pharma Eyes $10B Bid for U.S.’ Organon

at www.tipranks.com (Mon, 19-Jan 3:05 AM)

Organon Gains Strategic Edge with FDA Approval of First PERJETA Biosimilar POHERDY

Market Chameleon (Mon, 17-Nov 8:41 AM)

Adjusted Profitability Improves at Organon as Cost Controls Offset Modest Revenue Growth

Market Chameleon (Mon, 10-Nov 8:12 AM)

Organon Overhauls Leadership After Wholesaler Sales Investigation—Audit Finds Minimal Revenue Impact, Major Governance Actions

Market Chameleon (Mon, 27-Oct 8:26 AM)